Mark Perry Net Worth & Insider Trades

Mark Perry - Director, Global Blood Therapeutics, Inc

As of October 6, 2022

What is Mark Perry's Net Worth?

The current estimated net worth of Global Blood Therapeutics, Inc's Director, Mark Perry, is estimated to be about $73.26M . Mark Perry owns about 26,428 units of Global Blood Therapeutics, Inc common stock. In the last 7 years at Global Blood Therapeutics, Inc, Mark Perry has sold an estimated value of $4.19M worth.

What is Mark Perry's Past Insider Trading?

Mark Perry's largest purchase order was 53,600 units , worth over $1.18M on May 13, 2020. Mark Perry's largest sale order was 53,600 units , worth over $4.19M on May 13, 2020. In total, Mark Perry has made about 11 transactions over 7 years of their time at Global Blood Therapeutics, Inc. Mark Perry usually trades in June, with the busiest year in 2016, 2022 and 2020.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Mark Perry's' Mailing Address?

  • Mailing address is 176 West Blithedale Ave Mill Valley CA 94941 CA

Global Blood Therapeutics, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Ted Love, M.D. 2020 $661,250 - $11,778,840 $4,693,666 $467,000 $5,000 $17,605,756
Ted Love, M.D. 2019 $596,876 - $4,359,600 $4,595,717 $540,000 $5,000 $10,097,193
Ted Love, M.D. 2018 $568,750 - $4,648,800 $4,623,690 $414,000 $5,000 $10,260,240
David Johnson 2020 $463,750 - $4,037,361 $1,582,504 $234,000 $5,000 $6,322,615
David Johnson 2019 $453,125 - $1,211,000 $1,267,784 $250,000 $5,000 $3,186,909
David Johnson 2018 $355,000 $75,000 $1,897,750 $1,898,534 $169,000 $5,000 $4,394,284
Jeffrey Farrow 2020 $457,813 - $3,708,261 $1,582,504 $231,500 $5,000 $5,985,078
Jeffrey Farrow 2019 $440,625 - $1,211,000 $1,267,784 $244,000 $5,000 $3,168,409
Jeffrey Farrow 2018 $425,938 - $1,370,800 $1,326,469 $201,000 $5,000 $3,329,207
Jung Choi 2020 $433,125 - $3,708,261 $1,582,504 $219,000 $5,000 $5,947,890
Jung Choi 2019 $416,875 - $1,211,000 $1,267,784 $231,000 $5,000 $3,131,659
Jung Choi 2018 $392,063 - $1,370,800 $1,326,469 $185,000 $5,000 $3,279,332
Tricia Suvari 2020 $422,499 - $3,708,261 $1,582,504 $214,000 $5,000 $5,932,264
Tricia Suvari 2019 $403,125 - $1,211,000 $1,267,784 $223,000 $5,000 $3,109,909
Tricia Suvari 2018 $386,875 - $1,549,600 $1,515,964 $183,000 $5,000 $3,640,439
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1629137/000119312521136815/d97499ddef14a.htm

What are Global Blood Therapeutics, Inc's Past Insider Trades?

Global Blood Therapeutics, Inc's most recent insider trade came on September 6, 2022 by Jeffrey Farrow who sold 33,326 units worth $2.27M . In the last 7 years, insiders at Global Blood Therapeutics, Inc have sold an estimated value of $167.81M and bought an estimated value of $17.45M worth of shares. Insider trading is most common in June, with the busiest year in 2022. The most active traders at the company are Jung Choi, See Remarks,  Ted Love, President and CEO,  and Borga Tricia Suvari, Chief Legal Officer .

Global Blood Therapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...